A detailed history of Miracle Mile Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 3,191 shares of NVO stock, worth $336,076. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,191
Previous 5,520 42.19%
Holding current value
$336,076
Previous $787,000 51.84%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$119.07 - $145.42 $277,314 - $338,683
-2,329 Reduced 42.19%
3,191 $379,000
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $63,686 - $76,246
519 Added 10.38%
5,520 $787,000
Q1 2024

Apr 18, 2024

BUY
$102.11 - $135.92 $66,269 - $88,212
649 Added 14.91%
5,001 $642,000
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $88,306 - $106,082
1,006 Added 30.07%
4,352 $450,000
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $152,142 - $333,830
1,673 Added 100.0%
3,346 $304,000
Q2 2023

Jul 13, 2023

BUY
$155.98 - $172.65 $260,954 - $288,843
1,673 New
1,673 $270,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.